Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva recall — FDA D-0550-2026
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.